genOway Société anonyme Balance Sheet Health
Financial Health criteria checks 5/6
genOway Société anonyme has a total shareholder equity of €17.4M and total debt of €7.2M, which brings its debt-to-equity ratio to 41.6%. Its total assets and total liabilities are €31.8M and €14.5M respectively. genOway Société anonyme's EBIT is €1.6M making its interest coverage ratio 16.8. It has cash and short-term investments of €4.3M.
Key information
41.6%
Debt to equity ratio
€7.23m
Debt
Interest coverage ratio | 16.8x |
Cash | €4.26m |
Equity | €17.38m |
Total liabilities | €14.46m |
Total assets | €31.84m |
Recent financial health updates
These 4 Measures Indicate That genOway Société anonyme (EPA:ALGEN) Is Using Debt Reasonably Well
Jun 08We Think genOway Société anonyme (EPA:ALGEN) Can Stay On Top Of Its Debt
Sep 27We Think genOway Société anonyme (EPA:ALGEN) Has A Fair Chunk Of Debt
May 31We Think genOway Société anonyme (EPA:ALGEN) Has A Fair Chunk Of Debt
Nov 01Recent updates
These 4 Measures Indicate That genOway Société anonyme (EPA:ALGEN) Is Using Debt Reasonably Well
Jun 08genOway Société anonyme's (EPA:ALGEN) Price Is Right But Growth Is Lacking
Jan 20We Think genOway Société anonyme (EPA:ALGEN) Can Stay On Top Of Its Debt
Sep 27We Think genOway Société anonyme (EPA:ALGEN) Has A Fair Chunk Of Debt
May 31We Think genOway Société anonyme (EPA:ALGEN) Has A Fair Chunk Of Debt
Nov 01Financial Position Analysis
Short Term Liabilities: ALGEN's short term assets (€17.7M) exceed its short term liabilities (€8.4M).
Long Term Liabilities: ALGEN's short term assets (€17.7M) exceed its long term liabilities (€6.1M).
Debt to Equity History and Analysis
Debt Level: ALGEN's net debt to equity ratio (17.1%) is considered satisfactory.
Reducing Debt: ALGEN's debt to equity ratio has reduced from 59.1% to 41.6% over the past 5 years.
Debt Coverage: Insufficient data to determine if ALGEN's debt is well covered by operating cash flow.
Interest Coverage: ALGEN's interest payments on its debt are well covered by EBIT (16.8x coverage).